Central Corneal Thickness in Nepalese Glaucoma Patients and Glaucoma Suspects
Journal Title: Journal of Clinical Research and Ophthalmology - Year 2015, Vol 2, Issue 1
Abstract
Purpose: To compare central corneal thickness (CCT) among glaucoma patients, glaucoma suspects, and normal subjects and to determine its association with glaucoma severity in Nepalese population. Methods: This study included 400 eyes (149 glaucoma, 157 glaucoma suspects, 94 controls) of 400 participants examined in a glaucoma clinic and eye OPD in Nepal. CCT was measured by ultrasonic pachymetry. Results: CCT was significantly different among the study groups (P = 0.05), with the thinnest CCT in normal tension glaucoma (NTG) and thickest in ocular hypertension (OHT). CCT (in μm) was thinner in NTG (519.6 ± 31.6; P = 0.06) and primary open angle glaucoma (POAG) (524.5 ± 35.8; P = 0.026) than controls (536.6 ± 28.9); and it was thinner in POAG compared to primary angle closure glaucoma (PACG) (541.3 ± 50.5; P = 0.028) and OHT (559.8 ± 28.1; P = 0.017). In NTG, CCT was thinner compared to Glaucoma suspects (GS) (531.6 ± 35.0; P = 0.038), PACG (P = 0.008), and OHT (P =0.008).There was no correlation between CCT and visual field defect and CCT was not statistically different between early, moderate and severe POAG groups. Conclusions: We report that CCT in glaucoma suspects is similar to normal subjects and POAG, but thicker than NTG. These data will be important in clinically monitoring glaucoma suspects that are at increased risk of glaucoma. Our results may be population specific and further longitudinal studies are warranted to determine influence of CCT on glaucoma progression in this population.
Authors and Affiliations
Prakash Adhikari, Pratik Chettry, Madhu Thapa
Keywords
Related Articles
- EP ID EP230565
- DOI 10.17352/2455-1414.000007
- Views 123
- Downloads 0
Ocular Safety of Intravitreal Injections of Age-Related Macular Degeneration Treatments in a Prospective Observational Cohort Study in Europe
Purpose: Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (IVT)injections for age-related macular degeneration (AMD) treatments in Europe. Methods: Ophthalmologists prospectively...
Consumption of 12 Eggs per Week for 1 Year Signifi cantly Raises Serum Zeaxanthin Levels and Improves Glare Recovery in Patients with Early Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the number one form of blindness in older adults due to the degeneration of the macula of the eye. Lutein and zeaxanthin are carotenoids that accumulate in the macula and may hel...
Visual Impairment in Orbitofrontal and Sphenoidal Fibrous Dysplasia Associated with Sphenoid Sinus Mucocele
The orbitofrontal fibrous dysplasia is a rare, non-malignant disease that involves the development and thickening of craniofacial bones, causing facial asymmetry, visual, neurological and dental complications. Decreased...
Conjunctival Leaking Bleb after Cross-Linking using Ribofl avin and UVA: A Histopathological Study
Two conjunctival leaking blebs were excisioned to assess by histological methods the cellular effect after corneal cross-linking treatment. Sections were stained with hematoxylin-eosin and immunohistochemistry with the K...
Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant regarding vascular endothelia...